Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11932635 CRBN ligands and uses thereof

Patent 11932635 was granted and assigned to Kymera Therapeutics on March, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 21 Mar, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 21 Mar, 2024
Edits made to:
Infobox (+53 properties)
Article (+182 characters)
‌

 US Patent 11932635 CRBN ligands and uses thereof

Article

Patent abstract

The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of CRBN, and the treatment of CRBN-mediated disorders.

Infobox
Is a
Patent
Patent
0
Patent Applicant
Kymera Therapeutics
Kymera Therapeutics
0
Current Assignee
Kymera Therapeutics
Kymera Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
119326350
Patent Inventor Names
Arthur F. Kluge0
Nan Ji0
Nello Mainolfi0
Date of Patent
March 19, 2024
0
Patent Application Number
180592320
Date Filed
November 28, 2022
0
Patent Citations
‌
US Patent 7173015 Inhibition of Syk kinase expression
0
‌
US Patent 7208157 Proteolysis targeting chimeric pharmaceutical
0
‌
US Patent 7273920 Controlling protein levels in eucaryotic organisms
0
‌
US Patent 7307077 Heterocyclic compound and antitumor agent containing the same as effective ingredient
0
‌
US Patent 7390799 Apoptosis promoters
0
‌
US Patent 7402325 Supercritical carbon dioxide extract of pharmacologically active components from
0
‌
US Patent 7449458 Prodrugs of 2,4-pyrimidinediamine compounds and their uses
0
‌
US Patent 7501496 Anti-OX40L antibodies
0
‌
US Patent 7514444 Inhibitors of bruton's tyrosine kinase
0
‌
US Patent 7528143 Bi-aryl meta-pyrimidine inhibitors of kinases
0
‌
US Patent 7557210 2,4-pyrimidinediamine compounds and their uses
0
‌
US Patent 7598257 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
0
‌
US Patent 7622496 Modified lysine-mimetic compounds
0
‌
US Patent 7667039 1,3-dihydro-imidazo [4,5-C] quinolin-2-ones as lipid kinase inhibitors
0
‌
US Patent 7713943 Further use of protein kinase N beta
0
‌
US Patent 7781433 Pharmaceutical compounds
0
‌
US Patent 7932260 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
0
‌
US Patent 7989622 Phosphatidylinositol 3-kinase inhibitors and methods of their use
0
‌
US Patent 8138347 Quinoline derivatives as PI3 kinase inhibitors
0
‌
US Patent 8185616 Route designing method
0
‌
US Patent 8217035 Pyrimidine derivatives used as PI-3-kinase inhibitors
0
‌
US Patent 8338439 2,4-disubstituted pyrimidines useful as kinase inhibitors
0
‌
US Patent 8486941 Phenyl amino pyrimidine compounds and uses thereof
0
‌
US Patent 8906682 Methods for treatment of cancer
0
‌
US Patent 9500653 Small-molecule hydrophobic tagging of fusion proteins and induced degradation of same
0
‌
US Patent 9632089 Small-molecule hydrophobic tagging of fusion proteins and induced degradation of same
0
‌
US Patent 9694084 Methods to induce targeted protein degradation through bifunctional molecules
0
‌
US Patent 9750816 Methods to induce targeted protein degradation through bifunctional molecules
0
‌
US Patent 9770512 Methods to induce targeted protein degradation through bifunctional molecules
0
‌
US Patent 9821068 Methods to induce targeted protein degradation through bifunctional molecules
0
‌
US Patent 9969710 Heteroaryl compounds as IRAK inhibitors and uses thereof
0
‌
US Patent 10125114 Methods to induce targeted protein degradation through bifunctional molecules
0
‌
US Patent 10336744 1AP E3 ligase directed proteolysis targeting chimeric molecules
0
‌
US Patent 10874743 IRAK degraders and uses thereof
0
‌
US Patent 11512080 CRBN ligands and uses thereof
0
‌
US Patent 6949537 PI-3 kinase inhibitor prodrugs
0
‌
US Patent 7041298 Proteolysis targeting chimeric pharmaceutical
0
‌
US Patent 7071189 Heterocyclic compound and antitumor agent containing the same as active ingredient
0
‌
US Patent 7074620 Controlling protein levels in eucaryotic organisms
0
Patent Primary Examiner
‌
Deepak R Rao
0
CPC Code
‌
C07D 211/88
0
‌
A61K 31/45
0

Find more entities like US Patent 11932635 CRBN ligands and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo